GlassScriptPhysician profile
Gary S Ledley
NPI 1306807219
$9,204.20
in general payments reported to CMS, 2019-2025
35 companies · $897 in 2025
The $897 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $645 · 2021: $2,123 · 2022: $2,044 · 2023: $1,243 · 2024: $1,536 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,675.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,743.89 | 2020-2024 | Xarelto |
| Pfizer INC. | $1,029.89 | 2020-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $957.62 | 2020-2025 | Lifevest |
| Medtronic, INC. | $802.24 | 2021-2025 | Symplicity G3, Cobalt Dr Mri Surescan, Onyx Frontier |
| Sanofi-Aventis U.S. LLC | $648.89 | 2019-2024 | |
| Shockwave Medical, INC | $610.43 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $535.06 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $352.74 | 2019-2023 | Camzyos |
| Cordis US Corp. | $349.26 | 2023-2025 | Brite Tip Radianz, Mynx Venous Vcd, Mynx Control Venous |
| Astrazeneca Pharmaceuticals LP | $269.31 | 2020-2022 | |
| Abiomed | $217.20 | 2020-2025 | Impella |
| Boston Scientific Corporation | $210.95 | 2021-2025 | Watchman, Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.51 | 2019-2024 | Jardiance |
| Alnylam Pharmaceuticals INC. | $133.47 | 2020-2024 | Onpattro |
| Abbott Laboratories | $132.97 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $124.37 | 2021-2023 | Verquvo |
| Esperion Therapeutics, INC. | $103.55 | 2020-2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $85.22 | 2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $77.52 | 2023-2024 | |
| Cardiovascular Systems INC. | $72.24 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $72.06 | 2020-2025 | Acuson Freestyle Diagnostic Ultrasound System |
| Akcea Therapeutics, INC. | $60.49 | 2020-2021 | |
| Biosense Webster, INC. | $58.29 | 2021-2025 | Carto 3 |
| Terumo Medical Corporation | $55.96 | 2021-2022 | |
| Philips North America LLC | $53.32 | 2019 | |
| Cardinal Health 200 LLC | $46.10 | 2021 | |
| Novo Nordisk INC | $38.44 | 2024 | Wegovy |
| Chiesi USA, INC. | $25.79 | 2020 | |
| Heartflow, INC. | $25.32 | 2023 | Ffrct |
| Atricure, INC. | $23.96 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.74 | 2024 | |
| Medtronic Vascular, INC. | $16.75 | 2020 | |
| Teleflex LLC | $16.55 | 2025 | Guideliner |
| Impulse Dynamics (USA) INC. | $15.94 | 2020 | |
| Amarin Pharma, INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Ledley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.